SD

Siddharth Dube

Active Director Director DIN 10156484
DIN 10156484 First appointment Aug 2023 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2023
Shareholding value •••• Premium profile

About Siddharth Dube

Data last updated:

Siddharth Dube is a Director at Ruemex Drugs Private Limited (since 2023). The company operates in Chemicals. Ruemex Drugs Private Limited reported revenue of ₹13.5 Lakh (FY 2025).

DIN 10156484
Primary Designation Director
Industry Chemicals
First Appointment 25 Aug 2023
Oldest Company Age 5 yrs
Largest company Ruemex Drugs Private Limited · ₹13.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ruemex Drugs Private Limited U24299MP2021PTC056858
Director25 Aug 20232021₹13.5 Lakh (FY 2025)Active

Board colleagues of Siddharth Dube

Directorship timeline

Open interactive timeline →
Ruemex Drugs Private Limited
Premium access

Shareholding and investment profile for Siddharth Dube

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Siddharth Dube

Siddharth Dube currently holds 1 directorship: Ruemex Drugs Private Limited (Director, since 25 Aug 2023, revenue ₹13.5 Lakh (FY 2025)).

Siddharth Dube was first appointed on 25 Aug 2023 as Director at Ruemex Drugs Private Limited.

The current boards of Siddharth Dube's companies include Aslam Hussain (Ruemex Drugs Private Limited), Shekh Kulsum Almas (Ruemex Drugs Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available